Are heat shock proteins therapeutic target for Parkinson's disease?

被引:0
|
作者
Luo, Guang-Rui
Chen, Sheng
Le, Wei-Dong
机构
[1] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China
[2] Jiao Tong Univ, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2007年 / 3卷 / 01期
关键词
Parkinson's disease (PD); heat shock proteins (HSPs); ubiquitin-proteasome system (UPS); apoptosis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock proteins ( HSPs), known as molecular chaperone to assist protein folding, have recently become a research focus in Parkinson's disease ( PD) because the pathogenesis of this disease is highlighted by the intracellular protein misfolding and inclusion body formation. The present review will focus on the functions of different HSPs and their protective roles in PD. It is postulated that HSPs may serve as protein folding machinery and work together with ubiquitin- proteasome system ( UPS) to assist in decomposing aberrant proteins. Failure of UPS is thought to play a key role in the pathogenesis of PD. In addition, HSPs may possess anti- apoptotic effects and keep the homeostasis of dopaminergic neurons against stress conditions. The critical role of HSPs and recent discovery of some novel HSPs inducers suggest that HSPs may be potential therapeutic targets for PD and other neurodegenerative disorders.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 50 条
  • [41] Inflammatory gut as a pathologic and therapeutic target in Parkinson's disease
    Lee, Jea-Young
    Wang, Zhen-Jie
    Moscatello, Alexa
    Kingsbury, Chase
    Cozene, Blaise
    Farooq, Jeffrey
    Saft, Madeline
    Sadanandan, Nadia
    Gonzales-Portillo, Bella
    Zhang, Henry
    Esparza Salazar, Felipe
    Lezama Toledo, Alma Rosa
    Rivera Monroy, German
    Berlet, Reed
    Sanberg, Cyndy D.
    Sanberg, Paul R.
    Borlongan, Cesario, V
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [42] Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
    Burtscher, Johannes
    Syed, Muhammed Muazzam Kamil
    Lashuel, Hilal A.
    Millet, Gregoire P.
    MOVEMENT DISORDERS, 2021, 36 (04) : 857 - 861
  • [43] SRY as a potential therapeutic target for men with Parkinson's Disease
    Harley, V.
    MOVEMENT DISORDERS, 2021, 36 : S310 - S310
  • [44] Gut microbiota: a potential therapeutic target for Parkinson's disease
    José Fidel Baizabal-Carvallo
    Neural Regeneration Research, 2021, 16 (02) : 287 - 288
  • [45] The Epigenetics Changes in Parkinson's Disease: a Novel Therapeutic Target
    Yuan, Ti-Fei
    Li, Jiang
    Shan, Chun-Lei
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (04) : 299 - 300
  • [46] Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease
    Chen, Xiaoyan
    Xue, Bao
    Wang, Jun
    Liu, Haixia
    Shi, Limin
    Xie, Junxia
    NEUROSCIENCE BULLETIN, 2018, 34 (02) : 341 - 348
  • [47] Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease
    Xiaoyan Chen
    Bao Xue
    Jun Wang
    Haixia Liu
    Limin Shi
    Junxia Xie
    Neuroscience Bulletin, 2018, 34 (02) : 341 - 348
  • [48] Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease
    Zhu, Manlian
    Liu, Xia
    Ye, Yiru
    Yan, Xiumei
    Cheng, Yiwen
    Zhao, Longyou
    Chen, Feng
    Ling, Zongxin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease
    Baul, Himadri Shekhaar
    Manikandan, Ceera
    Sen, Dwaipayan
    BRAIN RESEARCH BULLETIN, 2019, 146 : 244 - 252
  • [50] Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
    Qinqin Wang
    Yingjun Liu
    Jiawei Zhou
    Translational Neurodegeneration, 4